Your session is about to expire
← Back to Search
Behavioral Intervention
Virtual Rehabilitation for Cancer Survivors
N/A
Recruiting
Led By Jennifer Jones, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
An indication for cancer rehabilitation (WHO-DAS score >5)
Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights
Study Summary
This trial tests an 8-week virtual cancer rehab program to help cancer survivors with physical and social functioning, anxiety, work, and quality of life. Researchers will study effectiveness and potential factors that may affect successful implementation.
Who is the study for?
This trial is for cancer survivors aged 18+ who've finished primary treatment within the last 2 years. It's open to those with breast, colorectal, head and neck cancers or lymphoma if they're responding well to ongoing therapies like immunotherapy. Participants need good enough English for the intervention, internet access, and a WHO-DAS score over 5 indicating a need for rehab.Check my eligibility
What is being tested?
The CaRE@Home program is being tested in this study. It's an 8-week virtual rehabilitation designed to help cancer survivors manage impairments related to their condition. The effectiveness of this online program on disability levels and other aspects like anxiety and quality of life will be measured across several Canadian centers.See study design
What are the potential side effects?
Since CaRE@Home is a non-medical virtual rehab intervention focusing on exercise and support, it doesn't have typical drug side effects. However, participants may experience general discomfort or fatigue associated with physical activity during rehabilitation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I need help because my daily activities are affected by my cancer.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Disability
Secondary outcome measures
30-second sit to stand test
Anxiety
Demographics
+11 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CaRE@Home interventionExperimental Treatment1 Intervention
Group II: Usual Care groupActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,476 Previous Clinical Trials
484,792 Total Patients Enrolled
Jennifer Jones, PhDPrincipal InvestigatorUHN Princess Margaret Cancer Centre
1 Previous Clinical Trials
117 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need help because my daily activities are affected by my cancer.I am still on maintenance therapy after my main cancer treatment and have responded well to it.My health condition prevents me from participating in rehabilitation.You have health conditions or injuries that make it unsuitable for you to do exercises that involve moving over long distances.I have been diagnosed with major depression.I have a neurological condition that significantly affects my thinking, memory, or language skills.I am 18 years old or older.I have early to mid-stage breast, colorectal, head and neck cancer, or lymphoma without plans for a transplant.I finished my first cancer treatment within the last 2 years.
Research Study Groups:
This trial has the following groups:- Group 1: CaRE@Home intervention
- Group 2: Usual Care group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are additional volunteers still sought for this clinical trial?
"Clinicaltrials.gov indicates that the trial is currently open to participants, with its inception on July 7th 2023 and an update posted at the end of the month."
Answered by AI
What is the projected participant count of this clinical trial?
"Affirmative, clinicaltrials.gov indicates that this medical research is actively enrolling participants as of July 31st 2023. The trial was initially posted on July 7th and requires 388 patients from one site specifically."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger